These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2259456)

  • 1. Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN).
    Przedborski S; Wright M; Fahn S; Cadet JL
    Neurosci Lett; 1990 Aug; 116(1-2):51-7. PubMed ID: 2259456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrile.
    Przedborski S; Wright M; Fahn S; Cadet JL
    Brain Res; 1989 Dec; 504(2):311-4. PubMed ID: 2532054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies.
    Cadet JL; Kuyatt B; Fahn S; De Souza EB
    Brain Res; 1987 Dec; 437(2):383-6. PubMed ID: 3435844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
    Cadet JL; Jackson-Lewis V; Fahn S
    Brain Res; 1988 Jul; 456(2):371-4. PubMed ID: 2463039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic evidence of [3H]neurotensin binding changes in discrete regions of brain in the rat model of persistent spasmodic dyskinesia induced by iminodipropionitrile.
    Przedborski S; Wright M; Fahn S; Cadet JL
    Neurosci Lett; 1989 Dec; 107(1-3):335-40. PubMed ID: 2616045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortical serotonin-2 (5-HT-2) receptors in the iminodipropionitrile (IDPN)-model of persistent dyskinesia in the rat.
    Cadet JL; Rothman RB
    Neuropeptides; 1987; 10(2):175-80. PubMed ID: 3683772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nigrotecto-reticulospinal pathways in the iminodipropionitrile (IDPN) model of spasmodic dyskinesias: a 2-deoxy-D-[1-14C]glucose study in the rat.
    Cadet JL; Della Puppa A; London E
    Brain Res; 1989 Apr; 484(1-2):57-64. PubMed ID: 2713701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.
    Pazos A; Palacios JM
    Brain Res; 1985 Nov; 346(2):205-30. PubMed ID: 4052776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats.
    Stennett R; Katz M; Jackson-Lewis V; Fahn S; Cadet JL
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1003-8. PubMed ID: 2477862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
    Ogawa N; Mizukawa K; Haba K; Sato H
    Eur Neurol; 1990; 30 Suppl 1():31-40. PubMed ID: 1968833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain.
    Iida K; Iwata E; Asanuma M; Asanuma SN; Gómez-Vargas M; Miyazaki I; Nakanishi T; Ogawa N
    Neurosci Res; 1998 Feb; 30(2):185-93. PubMed ID: 9579652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: behavioral and biochemical pharmacology.
    Cadet JL
    Neurosci Biobehav Rev; 1989; 13(1):39-45. PubMed ID: 2671832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased striatal opiate delta-receptors in the rat model of persistent dyskinesia induced by iminodipropionitrile.
    Cadet JL; Rothman RB
    Neurosci Lett; 1986 Dec; 72(1):84-6. PubMed ID: 3027623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
    Cadet JL; Taylor E; Freed WJ
    Pharmacol Biochem Behav; 1988 Feb; 29(2):381-5. PubMed ID: 2452450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptors in brain revisited.
    Palacios JM
    Brain Res; 2016 Aug; 1645():46-9. PubMed ID: 26740406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat.
    Langlais PJ; Huang PC; Gabay S
    J Neurosci Res; 1975; 1(5-6):419-35. PubMed ID: 1241588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain.
    Marcinkiewicz M; Vergé D; Gozlan H; Pichat L; Hamon M
    Brain Res; 1984 Jan; 291(1):159-63. PubMed ID: 6230136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
    Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
    Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.